3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
4
Sarcoma
1
Other hematologic neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
192
Leukemia
102
Burkitt Lymphoma
50
Lymphoma
49
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
30
Lymphoma, Large B-Cell, Diffuse
21
Leukemia, Lymphocytic, Chronic, B-Cell
21
Leukemia, Biphenotypic, Acute
21
Lymphoma, Non-Hodgkin
20
Lymphoma, Follicular
17
Recurrence
14
Lymphoma, Mantle-Cell
14
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma, Large-Cell, Immunoblastic
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
11
Lymphoma, Large-Cell, Anaplastic
9
Blast Crisis
8
Multiple Myeloma
7
Leukemia, Myeloid, Acute
7
Hematologic Neoplasms
7
Hodgkin Disease
6
Neoplasm, Residual
5
Myelodysplastic Syndromes
5
Lymphoma, T-Cell
5
Dendritic Cell Sarcoma, Interdigitating
5
Leukemia, T-Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Leukemia, B-Cell
4
Immunoblastic Lymphadenopathy
4
Waldenstrom Macroglobulinemia
3
Interventions
Doxorubicin
2
hydrocortisone hemisuccinate
1
Vincristine
1
Razoxane
1
Radiotherapy
1
Prednisone
1
Methotrexate
1
Mercaptopurine
1
Medical History Taking
1
Leucovorin
1
Laser-Doppler Flowmetry
1
Hydrocortisone
1
Exercise
1
Electrocardiography
1
Echocardiography, Stress
1
Dexrazoxane
1
Cytarabine
1
Blood Cell Count
1
Asparaginase
1
Anthropometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Vincristine
×
Other hematologic neoplasm
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled